Comparison

LS-180 cells

Item no. C0009006
Manufacturer Addexbio
Amount One Frozen vial
Category
Type Tumour Cells
Specific against Human (Homo sapiens)
Dry ice Yes
Citations 1.Bass, S. E., Sienkiewicz, P., Macdonald, C. J., Cheng, R. Y., Sparatore, A., Del Soldato, P., Roberts, D. D., Moody, T. W., Wink, D. A., and Yeh, G. C. Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. Clin Cancer Res, 15: 1964-1972, 2009.
2.Fukumori, S., Masago, M., Ishida, K., Kayano, Y., Taguchi, M., and Hashimoto, Y. Temperature-dependent specific transport of levofloxacin in human intestinal epithelial LS180 cells. Biopharm Drug Dispos, 30: 448-456, 2009.
3.Graber-Maier, A., Buter, K. B., Aeschlimann, J., Bittel, C., Kreuter, M., Drewe, J., and Gutmann, H. Effects of Curcuma extracts and curcuminoids on expression of P-glycoprotein and cytochrome P450 3A4 in the intestinal cell culture model LS180. Planta Med, 76: 1866-1870.
4.Ishida, K., Takaai, M., Yotsutani, A., Taguchi, M., and Hashimoto, Y. Membrane transport mechanisms of mizoribine in the rat intestine and human epithelial LS180 cells. Biol Pharm Bull, 32: 741-745, 2009.
5.Takaai, M., Morishita, H., Ishida, K., Taguchi, M., and Hashimoto, Y. Contribution of Na+-independent nucleoside transport to ribavirin uptake in the rat intestine and human epithelial LS180 cells. Eur J Pharmacol, 601: 61-65, 2008.
6.Yamasaki, D., Nakamura, T., Okamura, N., Kokudai, M., Inui, N., Takeuchi, K., Watanabe, H., Hirai, M., Okumura, K., and Sakaeda, T. Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells. Eur J Pharm Sci, 37: 126-132, 2009.
ECLASS 10.1 32160890
ECLASS 11.0 32160890
UNSPSC 41106509
Available
Description
Disease:
Colorectal adenocarcinoma
Origin:
Derived from a 58 year old female Caucasian with Dukes type B adenocarcinoma of the colon
Species:
Homo sapiens
Tissue:
Colon
Morphology:
Epithelial
Properties:
Adherent
Cytogenic data:
Tumorigenic, Modal no. 45 (2n=46)
Patient:
Female, Caucasian, 58 yrs of age
Medium:
AddexBio-formulated EMEM (C0005-01) + 10% FBS
Subculture:
1:2 to 1:4 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C
Freezing Medium:
Complete culture medium supplemented with 5% (v/v) DMSO
Biosafety Level: I
Sterility:
Bacteria: Negative
Yeast: Negative
Mycoplasma: Negative
Pathogens:
HIV: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Protein Expression: HLA A2, B13, B50, IL6, IL10, mucin
Isoenzymes: ADA, 1; ES-D, 1; G6PD, B; PEP-D, 1; PGD, A; PGM1, 1; PGM3, 2
DNA Profile (STR): Amelogenin: X ; CSF1PO: 10, 13; D13S317: 10; D16S539: 11, 13; D5S818: 10, 15; D7S820: 11, 9.3; THO1: 6, 7; TPOX: 8, 9; vWA: 15, 18 Mutations in LS-180 Cells
Citation Format:
If use of this culture results in a scientific publication, it should be cited in the publication as: LS-180 (AddexBio C0009006)
Related cells by Organ: Caco-2 cells
CMT-93 cells
COLO 205 cells
DLD-1 cells
HCA-7 cells
HCT-116 cells
HCT-8 cells
HCT-15 cells
HT-29 cells
LoVo cells
LS-180 cells
LS-174T cells
RKO cells
SNU-407 cells
SNU-503 cells
SW1116 cells
SW48 cells
SW480 cells
SW620 cells
T84 cells
Storage condition
LN2
Manufacturer - Category
Cell Lines

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: One Frozen vial
Available: In stock
available

Delivery expected until 12/25/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close